Search alternatives:
shape decrease » shape increases (Expand Search), showed decreased (Expand Search)
small decrease » small increased (Expand Search)
step decrease » sizes decrease (Expand Search), teer decrease (Expand Search), we decrease (Expand Search)
nn decrease » _ decrease (Expand Search), a decrease (Expand Search), mean decrease (Expand Search)
shape decrease » shape increases (Expand Search), showed decreased (Expand Search)
small decrease » small increased (Expand Search)
step decrease » sizes decrease (Expand Search), teer decrease (Expand Search), we decrease (Expand Search)
nn decrease » _ decrease (Expand Search), a decrease (Expand Search), mean decrease (Expand Search)
-
1661
YOLOv8 overall framework.
Published 2025“…For the purpose of further enhancing the processing capability of small-scale features, a small target detection head is first introduced to the detection layer of YOLOv8 in this paper with the aim of collecting more detailed information by increasing the detection resolution of YOLOv8 to ensure precise and fast detection. …”
-
1662
The performance of YOFGD model on MOT16.
Published 2025“…For the purpose of further enhancing the processing capability of small-scale features, a small target detection head is first introduced to the detection layer of YOLOv8 in this paper with the aim of collecting more detailed information by increasing the detection resolution of YOLOv8 to ensure precise and fast detection. …”
-
1663
Network structure of OSA.
Published 2025“…For the purpose of further enhancing the processing capability of small-scale features, a small target detection head is first introduced to the detection layer of YOLOv8 in this paper with the aim of collecting more detailed information by increasing the detection resolution of YOLOv8 to ensure precise and fast detection. …”
-
1664
The performance of S-YOFEO model on MOT17.
Published 2025“…For the purpose of further enhancing the processing capability of small-scale features, a small target detection head is first introduced to the detection layer of YOLOv8 in this paper with the aim of collecting more detailed information by increasing the detection resolution of YOLOv8 to ensure precise and fast detection. …”
-
1665
Five multi-target tracking evaluation indexes.
Published 2025“…For the purpose of further enhancing the processing capability of small-scale features, a small target detection head is first introduced to the detection layer of YOLOv8 in this paper with the aim of collecting more detailed information by increasing the detection resolution of YOLOv8 to ensure precise and fast detection. …”
-
1666
Algorithm flowchart of OFEO.
Published 2025“…For the purpose of further enhancing the processing capability of small-scale features, a small target detection head is first introduced to the detection layer of YOLOv8 in this paper with the aim of collecting more detailed information by increasing the detection resolution of YOLOv8 to ensure precise and fast detection. …”
-
1667
Partial tracking results of MOT17 dataset.
Published 2025“…For the purpose of further enhancing the processing capability of small-scale features, a small target detection head is first introduced to the detection layer of YOLOv8 in this paper with the aim of collecting more detailed information by increasing the detection resolution of YOLOv8 to ensure precise and fast detection. …”
-
1668
Improved detection layer.
Published 2025“…For the purpose of further enhancing the processing capability of small-scale features, a small target detection head is first introduced to the detection layer of YOLOv8 in this paper with the aim of collecting more detailed information by increasing the detection resolution of YOLOv8 to ensure precise and fast detection. …”
-
1669
The performance of S-YOFEO model on MOT16.
Published 2025“…For the purpose of further enhancing the processing capability of small-scale features, a small target detection head is first introduced to the detection layer of YOLOv8 in this paper with the aim of collecting more detailed information by increasing the detection resolution of YOLOv8 to ensure precise and fast detection. …”
-
1670
The matching process of EIOU.
Published 2025“…For the purpose of further enhancing the processing capability of small-scale features, a small target detection head is first introduced to the detection layer of YOLOv8 in this paper with the aim of collecting more detailed information by increasing the detection resolution of YOLOv8 to ensure precise and fast detection. …”
-
1671
60 Hz-induced neural entrainment.
Published 2025“…Statistical significance for these inter-group comparisons was assessed using the Wilcoxon rank-sum test. …”
-
1672
Table 1_The effect of self-compassion versus mindfulness interventions on autonomic responses to stress in generalized anxiety disorders.docx
Published 2025“…We also demonstrated a significant correlation between decreased heart rate response and less negative emotions.…”
-
1673
Bias risk assessment of included studies.
Published 2025“…Compared to standard treatment, QJHTD significantly improved pulmonary function, with increases in FEV1 (MD = 0.32, 95% CI [0.25, 0.38], <i>p </i>= 0.000), FVC (MD = 0.30, 95% CI [0.22, 0.37], <i>p </i>= 0.000), FEV1/FVC (MD = 5.58, 95% CI [4.81, 6.34], <i>p </i>= 0.000), and PaO<sub>2</sub> (MD = 9.62, 95% CI [6.17, 13.08], <i>p </i>= 0.000), and a decrease in PaCO<sub>2</sub> (MD = -9.12, 95% CI [–11.96, –6.28], <i>p </i>= 0.000). …”
-
1674
Forest plot for hs-CRP.
Published 2025“…Compared to standard treatment, QJHTD significantly improved pulmonary function, with increases in FEV1 (MD = 0.32, 95% CI [0.25, 0.38], <i>p </i>= 0.000), FVC (MD = 0.30, 95% CI [0.22, 0.37], <i>p </i>= 0.000), FEV1/FVC (MD = 5.58, 95% CI [4.81, 6.34], <i>p </i>= 0.000), and PaO<sub>2</sub> (MD = 9.62, 95% CI [6.17, 13.08], <i>p </i>= 0.000), and a decrease in PaCO<sub>2</sub> (MD = -9.12, 95% CI [–11.96, –6.28], <i>p </i>= 0.000). …”
-
1675
Forest plot for IL-6.
Published 2025“…Compared to standard treatment, QJHTD significantly improved pulmonary function, with increases in FEV1 (MD = 0.32, 95% CI [0.25, 0.38], <i>p </i>= 0.000), FVC (MD = 0.30, 95% CI [0.22, 0.37], <i>p </i>= 0.000), FEV1/FVC (MD = 5.58, 95% CI [4.81, 6.34], <i>p </i>= 0.000), and PaO<sub>2</sub> (MD = 9.62, 95% CI [6.17, 13.08], <i>p </i>= 0.000), and a decrease in PaCO<sub>2</sub> (MD = -9.12, 95% CI [–11.96, –6.28], <i>p </i>= 0.000). …”
-
1676
The incidence rate of adverse reactions.
Published 2025“…Compared to standard treatment, QJHTD significantly improved pulmonary function, with increases in FEV1 (MD = 0.32, 95% CI [0.25, 0.38], <i>p </i>= 0.000), FVC (MD = 0.30, 95% CI [0.22, 0.37], <i>p </i>= 0.000), FEV1/FVC (MD = 5.58, 95% CI [4.81, 6.34], <i>p </i>= 0.000), and PaO<sub>2</sub> (MD = 9.62, 95% CI [6.17, 13.08], <i>p </i>= 0.000), and a decrease in PaCO<sub>2</sub> (MD = -9.12, 95% CI [–11.96, –6.28], <i>p </i>= 0.000). …”
-
1677
The PRISMA study flowchart.
Published 2025“…Compared to standard treatment, QJHTD significantly improved pulmonary function, with increases in FEV1 (MD = 0.32, 95% CI [0.25, 0.38], <i>p </i>= 0.000), FVC (MD = 0.30, 95% CI [0.22, 0.37], <i>p </i>= 0.000), FEV1/FVC (MD = 5.58, 95% CI [4.81, 6.34], <i>p </i>= 0.000), and PaO<sub>2</sub> (MD = 9.62, 95% CI [6.17, 13.08], <i>p </i>= 0.000), and a decrease in PaCO<sub>2</sub> (MD = -9.12, 95% CI [–11.96, –6.28], <i>p </i>= 0.000). …”
-
1678
Forest plot for FEV1/FVC.
Published 2025“…Compared to standard treatment, QJHTD significantly improved pulmonary function, with increases in FEV1 (MD = 0.32, 95% CI [0.25, 0.38], <i>p </i>= 0.000), FVC (MD = 0.30, 95% CI [0.22, 0.37], <i>p </i>= 0.000), FEV1/FVC (MD = 5.58, 95% CI [4.81, 6.34], <i>p </i>= 0.000), and PaO<sub>2</sub> (MD = 9.62, 95% CI [6.17, 13.08], <i>p </i>= 0.000), and a decrease in PaCO<sub>2</sub> (MD = -9.12, 95% CI [–11.96, –6.28], <i>p </i>= 0.000). …”
-
1679
Forest plot for clinical efficacy.
Published 2025“…Compared to standard treatment, QJHTD significantly improved pulmonary function, with increases in FEV1 (MD = 0.32, 95% CI [0.25, 0.38], <i>p </i>= 0.000), FVC (MD = 0.30, 95% CI [0.22, 0.37], <i>p </i>= 0.000), FEV1/FVC (MD = 5.58, 95% CI [4.81, 6.34], <i>p </i>= 0.000), and PaO<sub>2</sub> (MD = 9.62, 95% CI [6.17, 13.08], <i>p </i>= 0.000), and a decrease in PaCO<sub>2</sub> (MD = -9.12, 95% CI [–11.96, –6.28], <i>p </i>= 0.000). …”
-
1680
Forest plot for FEV1.
Published 2025“…Compared to standard treatment, QJHTD significantly improved pulmonary function, with increases in FEV1 (MD = 0.32, 95% CI [0.25, 0.38], <i>p </i>= 0.000), FVC (MD = 0.30, 95% CI [0.22, 0.37], <i>p </i>= 0.000), FEV1/FVC (MD = 5.58, 95% CI [4.81, 6.34], <i>p </i>= 0.000), and PaO<sub>2</sub> (MD = 9.62, 95% CI [6.17, 13.08], <i>p </i>= 0.000), and a decrease in PaCO<sub>2</sub> (MD = -9.12, 95% CI [–11.96, –6.28], <i>p </i>= 0.000). …”